Cyclophosphamide for the treatment of central neurosarcoidosis: Retrospective study in 32 patients

Joint Bone Spine. 2023 May;90(3):105513. doi: 10.1016/j.jbspin.2022.105513. Epub 2022 Dec 15.

Authors

William Bigot¹, Catherine Chapelon-Abric², Olivier Mangin¹, Karine Champion¹, Stéphane Mouly¹, Patrice Cacoub², Damien Sène³

Affiliations

¹ Department of Internal Medicine, Lariboisière Hospital, 2, rue Ambroise Paré, 75010 Paris, France.
² Department of Internal medicine, Pitié-Salpêtrière Hospital, Paris, France.
³ Department of Internal Medicine, Lariboisière Hospital, 2, rue Ambroise Paré, 75010 Paris, France. Electronic address: damien.sene@aphp.fr.

PMID: 36528334
DOI: 10.1016/j.jbspin.2022.105513

No abstract available

Keywords: Central nervous system; Cyclophosphamide; Neurosarcoidosis; Sarcoidosis.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Central Nervous System Diseases* / diagnosis
Central Nervous System Diseases* / drug therapy
Cyclophosphamide
Humans
Retrospective Studies
Sarcoidosis* / diagnosis
Sarcoidosis* / drug therapy

Substances

Cyclophosphamide

Supplementary concepts

Neurosarcoidosis